The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-[2-Ethoxy-5-(1-imino-1-oxo-1lambda(6)-thiomorpholine-4-sulfonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one ID: ALA4759667
PubChem CID: 162658107
Max Phase: Preclinical
Molecular Formula: C21H28N6O5S2
Molecular Weight: 508.63
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CCCc1nc(C)c2c(=O)[nH]c(-c3cc(S(=O)(=O)N4CCS(=N)(=O)CC4)ccc3OCC)nn12
Standard InChI: InChI=1S/C21H28N6O5S2/c1-4-6-18-23-14(3)19-21(28)24-20(25-27(18)19)16-13-15(7-8-17(16)32-5-2)34(30,31)26-9-11-33(22,29)12-10-26/h7-8,13,22H,4-6,9-12H2,1-3H3,(H,24,25,28)
Standard InChI Key: SULSFJQHLIQKLR-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 37 0 0 0 0 0 0 0 0999 V2000
7.7249 -3.6458 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.3166 -4.3624 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
8.1414 -4.3577 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3499 -5.5958 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.1749 -5.5999 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
4.7661 -4.8834 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4694 -6.8416 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4682 -7.6689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1830 -8.0818 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8995 -7.6684 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8965 -6.8379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1812 -6.4288 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6122 -8.0790 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6115 -8.9050 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0395 -8.0802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3239 -7.6644 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.8920 -5.1892 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.6057 -5.6012 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3168 -5.1900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6030 -3.9521 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8856 -4.3649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7547 -7.6690 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0388 -8.9061 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3264 -9.3189 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4987 -10.1240 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.3177 -10.2088 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.6514 -9.4562 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.4581 -9.2835 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9476 -10.7378 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2036 -11.5221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6525 -12.1359 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1828 -8.9068 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.4682 -9.3191 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4680 -10.1441 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 2 0
5 4 2 0
6 5 2 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
13 14 2 0
13 16 1 0
14 24 1 0
23 15 1 0
15 16 1 0
10 13 1 0
12 5 1 0
5 17 1 0
17 18 1 0
17 21 1 0
18 19 1 0
19 2 1 0
2 20 1 0
20 21 1 0
15 22 2 0
23 24 1 0
24 25 1 0
25 26 2 0
26 27 1 0
27 23 2 0
27 28 1 0
25 29 1 0
29 30 1 0
30 31 1 0
9 32 1 0
32 33 1 0
33 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 508.63Molecular Weight (Monoisotopic): 508.1563AlogP: 1.80#Rotatable Bonds: 7Polar Surface Area: 150.58Molecular Species: NEUTRALHBA: 9HBD: 2#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 9.73CX Basic pKa: 2.62CX LogP: -0.42CX LogD: -0.42Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.49Np Likeness Score: -1.49
References 1. Mäder P,Kattner L. (2020) Sulfoximines as Rising Stars in Modern Drug Discovery? Current Status and Perspective on an Emerging Functional Group in Medicinal Chemistry., 63 (23.0): [PMID:32870008 ] [10.1021/acs.jmedchem.0c00960 ]